Stocktoria
Sight Sciences, Inc. SGHT
Nasdaq · XNAS · stock · Surgical & Medical Instruments & Apparatus · website · IPO 2021-07-15
Sight Sciences, Inc. statistics & valuation
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Gross margin | 86.2% | 85.5% | 85.3% | 82.7% | 82.4% |
| Operating margin | -48.0% | -63.3% | -70.7% | -117.7% | -105.2% |
| Net margin | -49.7% | -64.5% | -68.5% | -120.9% | -128.6% |
| FCF margin | -38.7% | -28.5% | -59.2% | -107.9% | -109.0% |
| Return on assets | -33.3% | -36.1% | -33.3% | -40.5% | -22.5% |
| Return on equity | -60.1% | -58.8% | -46.2% | -53.9% | -27.1% |
| Debt / equity | 0.66× | 0.46× | 0.29× | 0.22× | 0.15× |
| Current ratio | 10.22 | 9.04 | 13.29 | 11.77 | 20.52 |
| Revenue growth | -3.1% | -1.5% | 13.6% | 45.7% | 77.1% |
Source: SEC EDGAR filings · CIK 0001531177 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.